US Patent Issued to Aptevo Research and Development on Oct. 14 for "CD123 binding proteins and related compositions and methods" (Washington Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,798, issued on Oct. 14, was assigned to Aptevo Research and Development LLC (Seattle).

"CD123 binding proteins and related compositions and methods" was invented by Gabriela Hernandez-Hoyos (Seattle), Elaine T. Sewell (Seattle), Catherine J. McMahan (Seattle), David Bienvenue (Seattle), John W. Blankenship (Seattle), Danielle Mitchell (Seattle) and Peter Pavlik (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to protein molecules that specifically bind to CD123, which may have at least one humanized or human CD123-binding domain. Such molecules are useful for the treatment of cancer. The protein molecule binding...